Aptamer-Peptide Conjugates as Targeted Chemosensitizers for Breast Cancer TreatmentYan Tan, Weihong Tan, Yingying Li et al.|ACS Applied Materials & Interfaces|2020Cited by 44
Antibacterial Fusion Protein BPI21/LL-37 Modification Enhances the Therapeutic Efficacy of hUC-MSCs in SepsisLi Zhan, Xiang Xu, Luoquan Ao et al.|Molecular Therapy|2020Cited by 22
Aptamer Enables Consistent Maytansine Delivery through Maintaining Receptor Homeostasis for HER2 Targeted Cancer TherapyYan Tan, Weihong Tan, Xue‐Qiang Wang et al.|Bioconjugate Chemistry|2020Cited by 11